Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2012-02-06 |
| Study Made Public: | 2013-03-21 |
Title
Lai_CAVD18
Description
CAVD 282 (CAVIMC-043) is a guinea pig study assessing variants of Clade C ZM96 Env for their ability to induce binding antibodies.
Sign in to see full information about this study and to download study data.
Products
ZM96 gp140 ZM96gp140 DNA ZM96 gp140 A37 ZM96 gp140 A39 ZM96 gp140 A46 ZM96 gp140 A47 ZM96gp140 A37 DNA ZM96gp140 A39 DNA ZM96gp140 A46 DNA ZM96gp140 A47 DNA pCDNA 3.1Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.